She earned her PharmD from the University of North Carolina at Chapel Hill and completed a residency at the University of California San Diego Medical Center and fellowship at the University of Colorado Denver. Her research interests are determining concentration-effect relationships and investigating drug-drug interactions for antiviral drugs. Dr. Kiser’s laboratory is a leader in the development of state of the art analytical methods to quantitate antiviral drug concentrations in various biologic matrices. She is involved in several local, national, and international antiviral clinical pharmacology studies in persons with viral hepatitis and HIV.